Crude and residence-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)

Subjects:

Age- and sex- specific median yearly incidence (A) and mortality (B) rate of liver cancer per 10⁶ population over 2014–2023. by Ayana Ablayeva (22103708)

Subjects:

Regional and temporal burden of liver cancer in Kazakhstan (2014–2023). by Ayana Ablayeva (22103708)

Subjects:

The significance of predictor variables from the randomised (100) Poisson GLM models for the proximal group. by Stella Gachoki (16024540)

Reverse MR analysis data. by Ying Zhao (16546)

List of 1483 genes that were significantly (<i>P</i> < 0.1) increased or decreased in any galactose-treated sample. by Masaya Nagaya (13851123)

The significance of predictor variables from the randomised (100) Poisson GLM models for distant trap groups. by Stella Gachoki (16024540)

The results of GO functional enrichment analysis (Annotation: The higher the value, the greater the importance). by Lin Zhou (141050)

Duration of blood pressure decrease. by Ai Wei (120010)

Results of GO analysis showing significantly enriched biological process (BP), cellular component (CC) and molecular function (MF) in genes with significantly decreased expression... by Lucy Granat (5570813)

Propofol anesthesia or with surgery decreased the expression of BDNF and p-TrkB, but SAHA reversed the reduction. by Yunlin Feng (3043659)

Sobel test for the significance of the mediation effect. by Getachew Magnar Kitila (19935139)

Posterior, mid-posterior, central, and mid-anterior corpus callosal volume significantly decreased with increasing risk of environmental lead exposure. by Andrew T. Marshall (10159199)

SQFZ reverses constitutive and PI3K pathway-induced cisplatin resistance. by Bin Yan (32980)

Significant relationships between QOL measures on infusion day and day 7. by Jordan K. Abbott (8934239)

Subjects:

Table_1_Trans ε-Viniferin Decreases Amyloid Deposits With Greater Efficiency Than Resveratrol in an Alzheimer’s Mouse Model.pdf by Aline Freyssin (11912204)

“…Furthermore, a significant decrease in brain uptake of the TSPO PET tracer [¹⁸F]DPA-714 was observed with viniferin compared to resveratrol. …”

Image_1_Trans ε-Viniferin Decreases Amyloid Deposits With Greater Efficiency Than Resveratrol in an Alzheimer’s Mouse Model.pdf by Aline Freyssin (11912204)

“…Furthermore, a significant decrease in brain uptake of the TSPO PET tracer [¹⁸F]DPA-714 was observed with viniferin compared to resveratrol. …”

Image_3_Trans ε-Viniferin Decreases Amyloid Deposits With Greater Efficiency Than Resveratrol in an Alzheimer’s Mouse Model.pdf by Aline Freyssin (11912204)

“…Furthermore, a significant decrease in brain uptake of the TSPO PET tracer [¹⁸F]DPA-714 was observed with viniferin compared to resveratrol. …”

Image_2_Trans ε-Viniferin Decreases Amyloid Deposits With Greater Efficiency Than Resveratrol in an Alzheimer’s Mouse Model.pdf by Aline Freyssin (11912204)

“…Furthermore, a significant decrease in brain uptake of the TSPO PET tracer [¹⁸F]DPA-714 was observed with viniferin compared to resveratrol. …”

Table_2_Trans ε-Viniferin Decreases Amyloid Deposits With Greater Efficiency Than Resveratrol in an Alzheimer’s Mouse Model.pdf by Aline Freyssin (11912204)

“…Furthermore, a significant decrease in brain uptake of the TSPO PET tracer [¹⁸F]DPA-714 was observed with viniferin compared to resveratrol. …”